Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 6;22(1):1005.
doi: 10.1186/s12913-022-08378-4.

Task sharing in an interprofessional medication management program - a survey of general practitioners and community pharmacists

Collaborators, Affiliations

Task sharing in an interprofessional medication management program - a survey of general practitioners and community pharmacists

Robert Moecker et al. BMC Health Serv Res. .

Abstract

Background: Pharmacist-led medication review and medication management programs (MMP) are well-known strategies to improve medication safety and effectiveness. If performed interprofessionally, outcomes might even improve. However, little is known about task sharing in interprofessional MMP, in which general practitioners (GPs) and community pharmacists (CPs) collaboratively perform medication reviews and continuously follow-up on patients with designated medical and pharmaceutical tasks, respectively. In 2016, ARMIN (Arzneimittelinitiative Sachsen-Thüringen) an interprofessional MMP was launched in two German federal states, Saxony and Thuringia. The aim of this study was to understand how GPs and CPs share tasks in MMP when reviewing the patients' medication.

Methods: This was a cross-sectional postal survey among GPs and CPs who participated in the MMP. Participants were asked who completed which MMP tasks, e.g., checking drug-drug interactions, dosing, and side effects. In total, 15 MMP tasks were surveyed using a 5-point Likert scale ranging from "I complete this task alone" to "GP/CP completes this task alone". The study was conducted between 11/2020 and 04/2021. Data was analyzed using descriptive statistics.

Results: In total, 114/165 (69.1%) GPs and 166/243 (68.3%) CPs returned a questionnaire. The majority of GPs and CPs reported (i) checking clinical parameters and medication overuse and underuse to be completed by GPs, (ii) checking storage conditions of drugs and initial compilation of the patient's medication including brown bag review being mostly performed by CPs, and (iii) checking side-effects, non-adherence, and continuous updating of the medication list were carried out jointly. The responses differed most for problems with self-medication and adding and removing over-the-counter medicines from the medication list. In addition, the responses revealed that some MMP tasks were not sufficiently performed by either GPs or CPs.

Conclusions: Both GPs' and CPs' expertise are needed to perform MMP as comprehensively as possible. Future studies should explore how GPs and CPs can complement each other in MMP most efficiently.

Keywords: Interprofessional medication management; Medication review; Primary care; Survey; Task sharing.

PubMed Disclaimer

Conflict of interest statement

RM, MW, LW, WEH, and HMS declare they have received funding from the AOK PLUS. AK, PKK, and JF received funding from Department of Clinical Pharmacology and Pharmacoepidemiology. Furthermore, the following members of the ARMIN study group have contributed to program development and conduct: CE, UM, MS, AF, DB, UM, CD, MM, AA, UDK, AM, CH, SD, SF, KW.

Figures

Fig. 1
Fig. 1
Mean Likert scores of GPs (n = 112) and CPs (n = 163) responses regarding task sharing in MMP
Fig. 2
Fig. 2
Relative frequencies of distinct GP-CP pairs (n = 51) showing a sum score of < 100% (indicator of low mutual recognition) and > 100% in MMP tasks (indicator of high mutual recognition); sum score = 100 not shown

References

    1. Al-Babtain B, Cheema E, Hadi MA. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials. Res Social Adm Pharm. 2022;18:2559–2568. doi: 10.1016/j.sapharm.2021.04.022. - DOI - PubMed
    1. Jokanovic N, Tan EC, Sudhakaran S, et al. Pharmacist-led medication review in community settings: An overview of systematic reviews. Res Social Adm Pharm. 2017;13:661–685. doi: 10.1016/j.sapharm.2016.08.005. - DOI - PubMed
    1. Kwint H-F, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review. Drugs Aging. 2013;30:91–102. doi: 10.1007/s40266-012-0048-6. - DOI - PubMed
    1. Norton MC, Haftman ME, Buzzard LN. Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use. J Am Board Fam Med. 2020;33:745–753. doi: 10.3122/jabfm.2020.05.200044. - DOI - PubMed
    1. Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23:1966–1972. doi: 10.1007/s11606-008-0791-x. - DOI - PMC - PubMed

LinkOut - more resources